摘要
系统性硬化病是一类以皮肤纤维化为主要特征的多脏器受累的自身免疫性结缔组织病。在我国, 系统性硬化病的规范化诊疗依然欠缺。中华医学会风湿病学分会在借鉴国内外诊疗指南的基础上, 制定了本规范, 旨在规范我国系统性硬化病临床管理方案, 对评估疾病的关键方法予以解读, 并对疾病的治疗原则、方案给予建议。
Systemic sclerosis(SSc)is an autoimmune rheumatic disease that is characterized by skin fibrosis with multi-organ involvement.In China,the standardized diagnosis and treatment for SSc is still lacking.Based on the diagnosis criteria and guidelines from China and abroad,Chinese Rheumatology Association developed the current standardization of diagnosis and treatment for SSc.The purposes of this guideline are to standardize clinical management for SSc in China,to interpret the key evaluation tools for SSc,and to recommend therapeutic principle and strategies.
作者
邹和建
朱小霞
戴生明
王晓冰
赵东宝
赵岩
Zou Hejian;Zhu Xiaoxia;Dai Shengming;Wang Xiaobing;Zhao Dongbao;Zhao Yan(Division of Rheumatology,Huashan Hospital,Fudan University,Shanghai 200040,China;Department of Rheumatology and Immunology,Shanghai JiaoTong University Affiliated Sixth People′s Hospital,Shanghai 200233,China;Department of Rheumatology,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China;Department of Rheumatology and Immunology,the First Affiliated Hospital of Naval Medical University,Shanghai 200433,China;Department of Rheumatology and Clinical Immunology,Peking Union Medical College,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,National Clinical Research Center for Dermatologic and Immunologic Diseases,Ministry of Science&Technology,State Key Laboratory of Complex Severe and Rare Diseases,Key Laboratory of Rheumatology and Clinical Immunology,Ministry of Education,Beijing 100730,China)
出处
《中华内科杂志》
CAS
CSCD
北大核心
2022年第8期874-882,共9页
Chinese Journal of Internal Medicine
关键词
系统性硬化病
诊断
治疗
Systemic sclerosis
Diagnosis
Treatment
